- Home
- OIS vs EBS Comparison
OIS vs EBS Comparison
Compare OIS & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OIS | EBS |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | United States | United States |
| Employees | N/A | 900 |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.3M | 409.5M |
| IPO Year | 2000 | 2006 |
Fundamental Metrics
Financial Performance| Metric | OIS | EBS |
|---|---|---|
| Price | $12.20 | $7.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.00 | $12.00 |
| AVG Volume (30 Days) | ★ 1.0M | 910.7K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | N/A | ★ 0.93 |
| Revenue | ★ $1,088,133,000.00 | $742,900,000.00 |
| Revenue This Year | $3.73 | $1.29 |
| Revenue Next Year | $5.36 | N/A |
| P/E Ratio | ★ N/A | $8.53 |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $3.08 | $4.02 |
| 52 Week High | $14.50 | $14.06 |
Technical Indicators
Market Signals| Indicator | OIS | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 33.54 |
| Support Level | $11.52 | $7.72 |
| Resistance Level | $14.50 | $9.28 |
| Average True Range (ATR) | 0.49 | 0.30 |
| MACD | -0.16 | 0.09 |
| Stochastic Oscillator | 53.00 | 15.71 |
Price Performance
Historical ComparisonAbout OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to the energy, industrial and military sectors. Manufactured products include engineered capital equipment as well as products consumed in the drilling, well construction and production of oil and natural gas. The company sells its products and services to national oil and natural gas companies, oil and natural gas companies, onshore and offshore drilling companies and other oilfield services, defense and industrial companies. The company operates through three business segments, Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. It gains maximum revenue from Offshore Manufactured Products.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.